Aileron Therapeutics Inc. (ALRN)
NASDAQ: ALRN
· Real-Time Price · USD
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 10:00 PM
Aileron Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -59.15M | -61.27M | -62.88M | -29.24M | -25.22M | -18.07M | -15.73M | -12.94M | -17.48M | -23.69M | -27.33M | -29.58M | -29.92M | -27.61M | -26.16M | -24.36M | -22.68M | -21.38M |
Depreciation & Amortization | 1K | 4K | 63K | 115K | 127K | 135K | 119K | 110K | 141K | 171K | 169K | 166K | 162K | 160K | 121K | 91K | 66K | 95K |
Stock-Based Compensation | 1.16M | 1.23M | 1.12M | 1.25M | 975K | 949K | 1.19M | 1.34M | 1.56M | 1.78M | 2.08M | 2.27M | 2.48M | 2.32M | 2.26M | 2.02M | 1.82M | 2.02M |
Other Working Capital | 1.11M | 2.71M | 3.38M | 3.68M | 2.1M | -765K | -170K | -1.34M | -1.21M | 1.09M | -90K | 582K | -470K | -132K | 628K | 314K | 1.07M | -1.52M |
Other Non-Cash Items | 39.24M | 38.65M | 38.89M | 5.6M | 2.18M | 3.5M | 4.12M | -305K | -1.12M | -1.09M | -1M | -853K | 13K | -278K | -213K | -251K | -240K | 63K |
Deferred Income Tax | -1.55M | -1.55M | -1.55M | -4.12M | -4.12M | -4.12M | -4.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -918K | -259K | 1.37M | -2.18M | -333K | -3.52M | -5.38M | -2.04M | -3.05M | 296K | 420K | 495K | 258K | 333K | 242K | 317K | 1.06M | -2.07M |
Operating Cash Flow | -21.22M | -23.2M | -22.29M | -27.87M | -25.69M | -20.42M | -19.81M | -13.83M | -19.16M | -21.73M | -24.86M | -26.71M | -27M | -25.08M | -23.75M | -22.19M | -19.97M | -21.28M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -72K | -157K | -157K | -152.07K | -90.07K |
Cash Acquisitions | n/a | n/a | n/a | -96K | -54K | -54K | -54K | 42K | n/a | n/a | n/a | n/a | 66K | 66K | 66K | 66K | -0.00 | -0.00 |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.94M | -9.75M | -17.14M | -21.85M | -22.66M | -34.57M | -37.16M | -73.58M | -72.83M | -59.38M | -51.16M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 500K | 9M | 16.25M | 22.95M | 34.45M | 39.2M | 48.31M | 46.61M | 58.36M | 50.36M | 37.75M | 34.25M | 12.25M | 9M |
Other Investing Acitivies | n/a | n/a | n/a | 42K | 42.54K | 51.04K | 58.29K | 21.06K | 4.2M | 4.2M | 15.84M | 18.09M | 13.97M | 9.23M | -39.79M | -41.9M | -41.96M | -38.99M |
Investing Cash Flow | n/a | n/a | n/a | -96K | 446K | 8.95M | 16.2M | 21.06M | 24.7M | 22.06M | 26.46M | 23.95M | 23.85M | 13.19M | -35.92M | -38.52M | -47.14M | -42.11M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 12.62M | 26.17M | 25.44M | 33.9M | 34.02M | 15.76M | 15.76M | -33K | n/a | n/a | n/a | 1K | 27K | 53K | 53K | 52K | 26K | 11.26M |
Financial Cash Flow | 5M | 18.56M | 17.82M | 33.61M | 34.02M | 15.76M | 15.76M | -33K | n/a | n/a | n/a | 1K | 27K | 53K | 55.66M | 59.9M | 60.17M | 71.4M |
Net Cash Flow | -16.22M | -4.64M | -4.47M | 5.58M | 8.75M | 4.26M | 12.12M | 7.23M | 5.54M | 334K | 1.59M | -2.76M | -3.12M | -11.83M | -4.01M | -815K | -6.94M | 8.02M |
Free Cash Flow | -21.22M | -23.2M | -22.29M | -27.87M | -25.69M | -20.42M | -19.81M | -13.83M | -19.16M | -21.73M | -24.86M | -26.71M | -27M | -25.15M | -23.91M | -22.34M | -20.12M | -21.37M |